Medication Cost Information
I cannot provide specific cost information for Bevespi Aerosphere or Anoro Ellipta from the evidence provided, as none of the clinical guidelines, FDA drug labels, or research studies included contain pricing data for these medications.
What the Evidence Shows
The provided evidence focuses exclusively on:
- Clinical efficacy and safety profiles of these dual bronchodilator combinations for COPD management 1
- Pharmacological mechanisms and FDA-approved indications 2
- Comparative effectiveness between different LAMA/LABA combinations 3, 4
- Healthcare resource utilization and disease burden 5
While one study 6 examined cost-effectiveness of budesonide/formoterol versus fluticasone/vilanterol (showing costs around $733-767 USD per patient), this involved different medications and was conducted in Mexico's healthcare system, making it non-applicable to your question about Bevespi and Anoro pricing.
How to Obtain Actual Pricing
For accurate, current medication costs, you should:
- Contact your pharmacy directly - prices vary significantly by location, insurance coverage, and pharmacy benefit managers
- Check with the patient's insurance formulary - copays and coverage tiers differ substantially
- Explore manufacturer patient assistance programs - both AstraZeneca (Bevespi) and GSK (Anoro) offer savings programs
- Use prescription pricing tools like GoodRx, SingleCare, or RxSaver for cash price comparisons
Medication costs fluctuate based on insurance status, geographic location, pharmacy choice, and available discounts, making any single "typical cost" figure unreliable without these specific parameters.